Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

23

Revenue 2017

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

Teva

AZ’s Sean Bohen to exit after business overhaul; report

AZ’s Sean Bohen to exit after business overhaul; report

D. Soriot was himself the subject of departure speculation in 2017 when he was linked to a possible move to Israeli drugmaker Teva, at a time when the company was struggling ... Pascal Soriot, CEO, AZ. In the end Teva poached Lundbeck CEO Kåre Schultz

AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief

AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief After an apparently aborted move to become CEO at Teva in 2017, there remains speculation about Pascal Soriot moving on from AstraZeneca.

Generic Differentiation

Generic Differentiation lucrative. The latter is what we see when companies like Mylan or Teva copy good but aged small molecules.

Generic threat looms to J&J’s blockbuster Zytiga in US

Generic threat looms to J&J’s blockbuster Zytiga in US Generic drugmakers that have already won approval for generic Zytiga from the FDA include Mylan, Teva and Hikma Pharma and – with the injunction denied – there is nothing to stop them from

Is AstraZeneca looking for its next CEO?

Is AstraZeneca looking for its next CEO? Soriot is no stranger to the rumour mill: in July 2017 Reuters reported that he had agreed to take on the CEO role at Teva.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics